Wesley Mayer, MD
NPI 1952467367 · Urology Physician · Sugar Land, TX
Enrolled with Medicare as Practitioner - Urology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1952467367
- Entity type
- Individual
- Primary specialty
- Urology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- No
- License
- MT186259 (PA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
3 documented practice locations
- Medicare service volume (vs. specialty peers)25% of score
706 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 158 | $127 |
| Automated Urinalysis Test81003 | 78 | $2 |
| Urinalysis, Manual Test81002 | 75 | $3 |
| Limited Ultrasound Scan Behind Abdominal Cavity76775 | 63 | $61 |
| Psa (prostate Specific Antigen) Measurement, Total84153 | 52 | $18 |
| Analysis for Detection of Tumor Marker86316 | 52 | $20 |
| Psa (prostate Specific Antigen) Measurement, Free |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 10 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Tamsulosin Hcl | 207 | 72 |
| Finasteride | 110 | 44 |
| Potassium Citratebrand: Potassium Citrate Er | 64 | 19 |
| Mirabegronbrand: Myrbetriq | 46 | 13 |
| Chlorthalidone | 27 | — |
| Levofloxacin | 27 | 22 |
| Tramadol Hcl | 20 | 20 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$305 across 4 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Additional practice locations (2)
- 6560 Fannin StSuite 2100Houston, TX 77030-2761Phone: (713) 441-6455Fax: (713) 790-4456
- 6720 Bertner AveHouston, TX 77030-2604Phone: (823) 355-2666
Registry dates
- Enumerated
- 2006-12-29
- Last updated
- 2024-03-13
- Certified
- 2024-03-13
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.